Fresenius Purchase of NxStage Delayed Until August by FTC
The government shutdown delayed FTC approval of a Fresenius acquisition of NxStage Medical, Inc. The transaction is now expected to close in August 2019.
Read the full article » | Posted 02-14-2019
Related Articles
- Outset Halts Tablo Sales for Home Use Pending FDA Review of New Features Posted 07-13-2022
- Baxter Showcases Kidney Care Products Posted 06-10-2022
- DaVita and Medtronic to Launch New Kidney Tech Company Posted 06-10-2022
- Outset Tablo Could Boost Use of Home Hemodialysis Posted 05-12-2022